Scott Gottlieb
Schweiger Dermatology Group (United States)(US)
Publications by Year
Research Areas
Biomedical Ethics and Regulation, Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Pharmaceutical industry and healthcare, Healthcare Policy and Management
Most-Cited Works
- → Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis(1995)613 cited
- → The Wrinkle Severity Rating Scale(2004)262 cited
- → Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: A 10-year experience at a single institution(1996)214 cited
- → A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial(2019)168 cited
- → FDA Regulation of Mobile Medical Apps(2018)162 cited
- → Balancing Safety and Innovation for Cell-Based Regenerative Medicine(2018)157 cited